S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

By Bryant J.   Fisher B.   Gündüz N.   Costantino J.P.   Emir B.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite

Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

By Land Stephanie   Kopec Jacek   Yothers Greg   Anderson Stewart   Day Richard   Tang Gong   Ganz Patricia   Fisher Bernard   Wolmark Norman  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 153-164

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

By Jonsdottir Kristin   Zhang Hui   Jhagroe Darshni   Skaland Ivar   Slewa Aida   Björkblom Benny   Coffey Eleanor   Gudlaugsson Einar   Smaaland Rune   Janssen Emiel   Baak Jan  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory cells in node-negative breast cancer

By Löfdahl Britta   Ahlin Cecilia   Holmqvist Marit   Holmberg Lars   Zhou Wenjing   Fjällskog Marie-Louise   Amini Rose-Marie  

Acta Oncologica, Vol. 51, Iss. 5, 2012-05 ,pp. : 680-686

Informa Healthcare

Access to resources Recommend Favorite

A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2241-2249

Spandidos Publications

Access to resources Recommend Favorite